New Millennium Group »

Corcept Therapeutics Incorporated shares owned by New Millennium Group

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by New Millennium Group from 13F filings

Historical chart of New Millennium Group investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by New Millennium Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by New Millennium Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.9k 97 50.39
2024-09-30 $4.6k 99 46.28
2024-06-30 $3.8k 116 32.49

More positions owned by New Millennium Group

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Select Sector Spdr Tr Communication (XLC)
Select Sector Spdr Tr Financial (XLF)
Global X Fds Us Infr Dev Etf (PAVE)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)
Adma Biologics (ADMA)
Schwab Strategic Tr Fundamental Us S (FNDA)

View all positions for New Millennium Group

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Novo A/S
Geode Capital Management
Arrowstreet Capital, Limited Partnership
FMR
First Trust Advisors
Jacobs Levy Equity Management
Charles Schwab Investment Management
Northern Trust

View all funds holding Corcept Therapeutics Incorporated